| abstract |
Methods and compositions are provided for obtaining functionally enhanced differentiation effector cells resulting from the induced differentiation of genome engineered iPSCs. Derivative cells provided herein have stable and functional genome editing that delivers improved or enhanced therapeutic effects. Also provided are therapeutic compositions and uses thereof comprising functionally enhanced differentiation effector cells, alone or in combination with an antibody or checkpoint inhibitor in combination therapy. |